Barclays »

Lucid Diagnostics shares owned by Barclays

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $101k 100k 1.01
2025-06-30 $138k 120k 1.15
2025-03-31 $2.0k 1.6k 1.26
2022-03-31 $2.0k 822 2.43

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Lucid Diagnostics

Vanguard Group
Masters Capital Mgmt
BlackRock
Two Seas Capital
AWM Investment Company
Ghisallo Capital Management
Standard Life Aberdeen
Geode Capital Management
Alyeska Investment Group
Perkins Capital Management
State Street Corporation
Luminus Management
Wells Fargo & Company
Goldman Sachs Group
Northern Trust

View all funds holding Lucid Diagnostics